![Jeffery J. Anderson](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jeffery J. Anderson
Keine laufenden Positionen mehr
Karriereverlauf von Jeffery J. Anderson
Ehemalige bekannte Positionen von Jeffery J. Anderson
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
OTONOMY | Technik-/Wissenschafts-/F&E-Leiter | - | 01.12.2022 |
Ausbildung von Jeffery J. Anderson
Indiana University | Doctorate Degree |
University of Dayton | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 4 |
Operativ
Chief Tech/Sci/R&D Officer | 1 |
Doctorate Degree | 1 |
Undergraduate Degree | 1 |
Sektoral
Consumer Services | 3 |
Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Otonomy, Inc.
![]() Otonomy, Inc. BiotechnologyHealth Technology Otonomy, Inc. operates as a biopharmaceutical company. engages in the development of therapeutics for neurotology. The firm’s product pipeline includes OTIVIDEX (dexamethasone) Meniere's disease, OTIPRIO (ciprofloxacin otic suspension) acute otitis media with tubes (AOMT), OTO-313 (gacyclidine) tinnitus, OTO-413 (BDNF) hidden hearing Loss, OTO-510 (otoprotectant) prevent CIHL, OTO-6XX (hair cell regeneration) severe hearing loss. It operates under the Otiprio brand. The company was founded by Jay B. Lichter, Jeffrey Harris, Rick Friedman, and Allen F. Ryan on May 6, 2008 and is headquartered in San Diego, CA. | Health Technology |
- Börse
- Insiders
- Jeffery J. Anderson
- Erfahrung